Results 1 to 10 of about 28,782 (216)

Normal Tissue Integral Dose as a Result of Prostate Radiation Therapy: A Quantitative Comparison Between High-Dose-Rate Brachytherapy and Modern External Beam Radiation Therapy Techniques

Advances in Radiation Oncology, 2023
Purpose: Quantification of integral radiation dose delivered during treatment for prostate cancer is lacking. We performed a comparative quantification of dose to nontarget body tissues delivered via 4 common radiation techniques: conventional volumetric
Vincent P. Grzywacz, MD, Jessica D. Arden, MD, PhD, Nikhil P. Mankuzhy, MD, Gary S. Gustafson, MD, Evelyn A. Sebastian, BS, Veronica L. Abbott, MS, Kailee J. Walters, MS, Julie A. Puzzonia, MS, Amy S. Limbacher, BS, Jason M. Hafron, MD, Daniel J. Krauss, MD   +10 more
doaj   +1 more source

New technologies and machines for stereotactic radiation therapy

Precision Radiation Oncology, 2022
Stereotactic radiosurgery and stereotactic body radiation therapy have been increasingly utilized in radiation oncology to treat early stage tumors, metastatic targets, and retreatment of relapsed diseases due to their efficiency, treatment effect, and ...
Brian Wang, Jun Yang
doaj   +1 more source

Combination of Pembrolizumab and Stereotactic Body Radiation Therapy in Recurrent Metastatic Penile Squamous Cell Carcinoma: A Case Study

Biomedicines, 2022
The prognosis for patients with penile squamous cell carcinoma metastatic to regional lymph nodes or distant sites remains poor with limited treatment options, especially after the failure of first-line chemotherapy. Clinical trials evaluating the use of
Dalia Kaakour, Steven Seyedin, Roozbeh Houshyar, Nataliya Mar   +3 more
doaj   +1 more source

Local Control Following Stereotactic Body Radiation Therapy for Liver Oligometastases: Lessons from a Quarter Century

Current Oncology, 2023
The utilization of stereotactic body radiation therapy for the treatment of liver metastasis has been widely studied and has demonstrated favorable local control outcomes.
Sara Mheid, Stefan Allen, Sylvia S. W. Ng, William A. Hall, Nina N. Sanford, Todd A. Aguilera, Ahmed M. Elamir, Rana Bahij, Martijn P. W. Intven, Ganesh Radhakrishna, Issa Mohamad, Jeremy De Leon, Hendrick Tan, Shirley Lewis, Cihan Gani, Teo Stanecu, Veronica Dell’Acqua, Ali Hosni   +17 more
doaj   +1 more source

Helical IMRT-Based Stereotactic Body Radiation Therapy Using an Abdominal Compression Technique and Modified Fractionation Regimen for Small Hepatocellular Carcinoma

Technology in Cancer Research & Treatment, 2020
Purpose: To assess the efficacy and safety of stereotactic body radiation therapy using an abdominal compression technique and modified fractionation regimen (5-10 fractions) in patients with small-sized hepatocellular carcinoma.
Yi-Xing Chen MD, PhD, Yuan Zhuang MD, PhD, Ping Yang MD, Jia Fan MD, PhD, Jian Zhou MD, PhD, Yong Hu BS, Wen-Chao Zhu BS, Jing Sun MD, Zhao-Chong Zeng MD, PhD   +8 more
doaj   +1 more source

Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost in Patients With Spinal Metastases

Technology in Cancer Research & Treatment, 2020
Stereotactic body radiation therapy in patients with spine metastases maximizes local tumor control and preserves neurologic function. A novel approach could be the use of stereotactic body radiation therapy with simultaneous integrated boost delivering ...
Antonio Pontoriero MD, Giuseppe Iatì MD, Alberto Cacciola MD, Alfredo Conti MD, PhD, Anna Brogna PhD, Carmelo Siragusa PhD, Gianluca Ferini MD, Valerio Davì MD, Consuelo Tamburella MD, Laura Molino MD, Domenico Cambareri MD, Cesare Severo MD, Silvana Parisi MD, Nicola Settineri PhD, Isidora Ielo PhD, Stefano Pergolizzi MD   +15 more
doaj   +1 more source

Systemic therapy‐based split‐course stereotactic body radiation therapy

Precision Radiation Oncology, 2022
Purpose Given the therapeutic toxicity of concurrent chemoradiotherapy, the dose of chemotherapy is always limited. Hence, the question of how to administer adequate chemotherapy to synchronize stereotactic body radiation therapy (SBRT) treatment ...
Rong Zheng, Bisi Wang, Feihong Liang, Benhua Xu   +3 more
doaj   +1 more source

Stereotactic body radiation therapy for colorectal liver metastases

International Journal of Hyperthermia, 2022
Multidisciplinary case discussion of patients with colorectal liver metastases (CRLM) has led to improved selection of more complex patients with the oligometastatic disease for treatment with surgical resection, locally ablative therapy or a combination
Issa Mohamad, Aisling Barry, Laura Dawson, Ali Hosni   +3 more
doaj   +1 more source

Radiotherapy for Locally Advanced Pancreatic Adenocarcinoma—A Critical Review of Randomised Trials

Current Oncology, 2023
Pancreatic cancer is rising as one of the leading causes of cancer-related death worldwide. Patients often present with advanced disease, limiting curative treatment options and therefore making management of the disease difficult.
Mathilde Weisz Ejlsmark, Tine Schytte, Uffe Bernchou, Rana Bahij, Britta Weber, Michael Bau Mortensen, Per Pfeiffer   +6 more
doaj   +1 more source

Lung Stereotactic Body Radiation Therapy (SBRT) dose gradient and PTV volume: a retrospective multi-center analysis

Radiation Oncology, 2019
Background The treatment of lung lesions with stereotactic body radiation therapy calls for highly conformal dose, which is evaluated by a number of metrics. Lung stereotactic body radiation therapy clinical trials constrain a plans gradient index.
David Hoffman, Irena Dragojević, Jeremy Hoisak, David Hoopes, Ryan Manger   +4 more
doaj   +1 more source